SCHEMBL6569310

SCHEMBL6569310

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CONNOC[C@H]2O[C@@H](n3cnc4c(N)ncnc43)[C@H](O)[C@@H]2O)[C@@H](O)[C@H]1O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 3/20 0.73
SMN1; SMN2 Q16637 3/20 0.73
ADORA3 P0DMS8 2/20 0.73
ADORA2A P29274 2/20 0.73
ADORA2B P29275 2/20 0.73
DPP4 P27487 1/20 0.73
MEN1 O00255 1/20 0.73
SLC28A1 O00337 1/20 0.73
MAP3K7 O43318 1/20 0.73
SLC28A2 O43868 1/20 0.73
GAPDH P04406 1/20 0.73
MAPK1 P28482 1/20 0.73
STAT6 P42226 1/20 0.73
PI4KA P42356 1/20 0.73
KMT2A Q03164 1/20 0.73
PI4K2B Q8TCG2 1/20 0.73
DOT1L Q8TEK3 1/20 0.73
SLC29A1 Q99808 1/20 0.73
PI4K2A Q9BTU6 1/20 0.73
SLC28A3 Q9HAS3 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL939593 0.92 ADORA1 (0.71) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL8708990 0.92 ADORA1 (0.71) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL4650247 0.91 IARS1 (0.69) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL1723484 0.89 P2RY1 (0.70) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL937575 0.89 AHCY (0.63) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL10997946 0.88 ADORA1 (0.76) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL2040670 0.88 ADORA1 (0.76) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL5024895 0.88 ADORA1 (0.76) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL12963362 0.88 ADORA1 (0.76) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B
SCHEMBL481524 0.88 ADORA1 (0.76) ADORA1SMN1; SMN2ADORA3ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0727959-B1 DIAGNOSTIC USES OF HYDRAZINOADENOSINES ADERIS PHARMACEUTICALS INC (US) 2004-10-20 EP disclosed
EP-0727959-A4 DIAGNOSTIC USES OF HYDRAZINOADENOSINES DISCOVERY THERAPEUTICS INC (US) 2000-11-08 EP disclosed
EP-0567094-B1 Hydrazoadenosines DISCOVERY THERAPEUTICS INC (US) 1999-03-03 EP disclosed
EP-0727959-A1 DIAGNOSTIC USES OF HYDRAZINOADENOSINES Discovery Therapeutics, Inc. (US) 1996-08-28 EP disclosed
US-5477857-A Measuring myocardial function in mammals DISCOVERY THERAPEUTICS, INC. (US) 1995-12-26 US disclosed
WO-1995007049-A1 DIAGNOSTIC USES OF HYDRAZINOADENOSINES DISCOVERY THERAPEUTICS, INC. (US) 1995-03-16 WO disclosed
EP-0567094-A2 Hydrazoadenosines Discovery Therapeutics, Inc. (US) 1993-10-27 EP disclosed